Yann Le Cam

Yann Le Cam, Chief Executive Officer of EURORDIS, was recently appointed to the Management Board of the European Medicines Agency (EMA). Here he explains that his appointment is a tribute to the entire rare disease and patient community. The EMA Board is made up of representatives of each of the 28 EU Member States, the European Commission, the European Parliament, two civil society organizations, and doctor and veterinarian organizations.